Montgomery Community Media

The Gaithersburg biotechnology company, Novavax, announced Monday morning data from phase 3 of its COVID-19 vaccine trials which were conducted in the United States and Mexico. Novavax found that the trial, which began in December and enrolled 29,960 participants, had an overall efficacy rate of 90.04%. Last year, Novavax was awarded $1.6 billion from the […]

Researchers at the Silver Spring-based Walter Reed Army Institute of Research (WRAIR) are looking for volunteers to participate in a Phase 1 clinical trial of a new type of COVID-19 vaccine. Phase 1 of the trial will examine the vaccine’s safety and will look to generate an immune response that researchers expect to find, according […]

Novavax confirmed high levels of vaccine efficacy against both original and variant COVID-19 strains in recent United Kingdom and South Africa trials. In a press release Thursday, the Gaithersburg-based drug company said its vaccine has shown to provide 100% protection against severe disease, including hospitalizations and deaths. In a Phase 3 trial, Novavax reported a […]

Novavax, a vaccine development company headquartered in Gaithersburg, has initiated Phase 3 for its COVID-19 vaccine candidate.  It is the fifth candidate to reach Phase 3 in the U.S., after Pfizer, Moderna, AstraZeneca and Janssen. Novavax is looking for volunteers to participate in vaccine trials, particularly those who are part of at-risk populations like Hispanics, […]